dMed Competitors and Similar CompaniesClear all
dMed's competitors and similar companies include Faes Farma, InsightRX, Apeloa Pharmaceutical and Karyopharm Therapeutics.
 dMed dMed is a biopharmaceutical company that facilitates the globalization of innovative drugs, accelerates the development of medicines and improves clinical development capabilities. |  Faes Farma Faes Farma is a pharmaceutical company that develops, produces and commercializes pharmaceutical products and raw materials. |  InsightRX InsightRX is a company that specializes in precision medicine and clinical analytics designed to individualize treatment for the healthcare and biopharmaceutical sectors. |  Apeloa Pharmaceutical Apeloa Pharmaceutical (普洛药业股份有限公司) is a company that develops and produces pharmaceutical products. |  Karyopharm Therapeutics Karyopharm Therapeutics is a commercial-stage pharmaceutical company that pioneers in cancer therapies. | |
Founding Date | Founding Date 2016 | Founding Date 1933 | Founding Date 2015 | Founding Date 1989 | Founding Date 2008 |
Type | Type Private | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Morrisville, US HQ | Locations Leioa, ES HQ Madrid, ES Atlanta, US | Locations San Francisco, US HQ | Locations CN HQ | Locations Newton, US HQ Givatayim, IL |
Employees | Employees 172 | Employees 1,775 | Employees 274% increase | Employees 7,060 | Employees 22818% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.2 b | Valuation ($) N/A | Valuation ($) 2.7 b | Valuation ($) 111.7 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €493.6m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) ¥9.7b (FY, 2025) | Revenue (est.) $146.1m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods €167.1m (FY, 2024) | Cost of goods N/A | Cost of goods ¥7.2b (FY, 2025) | Cost of goods $5.9m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit €342.9m (FY, 2024) | Gross profit N/A | Gross profit ¥2.5b (FY, 2025) | Gross profit $140.1m (FY, 2025) |
Net income | Net income N/A | Net income €111.1m (FY, 2024) | Net income N/A | Net income ¥890.7m (FY, 2025) | Net income ($196m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 50m (almost 5 years ago) | Latest funding round N/A | Latest funding round $ 10m (over 6 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 208m | Total funding raised N/A | Total funding raised $ 12.8m | Total funding raised N/A | Total funding raised $ 248.7m |
For sources of this data, please see the company profile
View Company Profiles
Faes Farma
HQ
Leioa, ES
Employees
1,775
Faes Farma is a pharmaceutical company that develops, produces and commercializes pharmaceutical products and raw materials.
View companyInsightRX
HQ
San Francisco, US
Employees
27↑ 4% increase
InsightRX is a company that specializes in precision medicine and clinical analytics designed to individualize treatment for the healthcare and biopharmaceutical sectors.
View companyApeloa Pharmaceutical
HQ
CN
Employees
7,060
Apeloa Pharmaceutical (普洛药业股份有限公司) is a company that develops and produces pharmaceutical products.
View companyKaryopharm Therapeutics
HQ
Newton, US
Employees
228↓ 18% decrease
Karyopharm Therapeutics is a commercial-stage pharmaceutical company that pioneers in cancer therapies.
View company